{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:57:49Z","timestamp":1790243869531,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017981","name":"Sysmex Corp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017981","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2137"],"award-info":[{"award-number":["JPMJSP2137"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jbc.2024.107651","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T20:52:20Z","timestamp":1723063940000},"page":"107651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding"],"prefix":"10.1016","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6389-581X","authenticated-orcid":false,"given":"Hiroyuki","family":"Hiratsuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-909X","authenticated-orcid":false,"given":"Yasushi","family":"Akahori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Maeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Egashira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shiku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.107651_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-023-05707-3","article-title":"CAR immune cells: design principles, resistance and the next generation","volume":"614","author":"Labanieh","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107651_bib2","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.4049\/jimmunol.176.12.7308","article-title":"Quantifying and imaging NY-ESO-1\/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptors","volume":"176","author":"Purbhoo","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jbc.2024.107651_bib3","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/s41591-021-01436-0","article-title":"CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial","volume":"27","author":"Spiegel","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2024.107651_bib4","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41590-020-0719-0","article-title":"Inefficient CAR-proximal signaling blunts antigen sensitivity","volume":"21","author":"Gudipati","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2024.107651_bib5","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216352120","article-title":"Inefficient exploitation of accessory receptors reduces the sensitivity of chimeric antigen receptors","volume":"120","author":"Burton","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107651_bib6","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.4049\/jimmunol.1000173","article-title":"Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function","volume":"184","author":"Schmid","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jbc.2024.107651_bib7","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1073\/pnas.1221609110","article-title":"T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy","volume":"110","author":"Zhong","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107651_bib8","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1073\/pnas.1000966107","article-title":"Fast on-rates allow short dwell time ligands to activate T cells","volume":"107","author":"Govern","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107651_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/mto.2016.23","article-title":"An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity","volume":"3","author":"Maus","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.jbc.2024.107651_bib10","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1158\/1535-7163.MCT-19-1109","article-title":"Shaping functional avidity of CAR T cells: affinity, avidity, and antigen density that regulate response","volume":"20","author":"Greenman","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2024.107651_bib11","article-title":"Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1\/HLA-A2 for cancer immunotherapy","volume":"10","author":"Liu","year":"2022","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.jbc.2024.107651_bib12","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/bloodadvances.2022008304","article-title":"Therapeutic targeting of PRAME with mTCRCAR T cells in acute myeloid leukemia","volume":"7","author":"Kirkey","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.jbc.2024.107651_bib13","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.4049\/jimmunol.169.2.1110","article-title":"TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity","volume":"169","author":"Chames","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jbc.2024.107651_bib14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41587-022-01567-w","article-title":"Facile repurposing of peptide-MHC-restricted antibodies for cancer immunotherapy","volume":"41","author":"Yang","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbc.2024.107651_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","article-title":"Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor","volume":"6","author":"Ikeda","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2024.107651_bib16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2005.07.003","article-title":"The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling","volume":"122","author":"Epping","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107651_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12770","article-title":"The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer","volume":"53","author":"Xu","year":"2020","journal-title":"Cell Prolif."},{"key":"10.1016\/j.jbc.2024.107651_bib18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/protein\/gzt053","article-title":"Improving the affinity of an antibody for its antigen via long-range electrostatic interactions","volume":"26","author":"Fukunaga","year":"2013","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.jbc.2024.107651_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41598-021-03784-w","article-title":"Improvement of the affinity of an anti-rat P2X4 receptor antibody by introducing electrostatic interactions","volume":"12","author":"Shinozaki","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2024.107651_bib20","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1073\/pnas.92.5.1257","article-title":"Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity","volume":"92","author":"Roost","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107651_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-065X.1987.tb00507.x","article-title":"Mutation drift and repertoire shift in the maturation of the immune response","volume":"96","author":"Berek","year":"1987","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jbc.2024.107651_bib22","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.4049\/jimmunol.173.12.7647","article-title":"T\u00a0cell activation by antibody-like immunoreceptors: increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity","volume":"173","author":"Chmielewski","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jbc.2024.107651_bib23","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1158\/0008-5472.CAN-15-0159","article-title":"Affinity-tuned ErbB2 or EGFR chimeric antigen receptor T cells exhibit an increased therapeutic index against tumors in mice","volume":"75","author":"Liu","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2024.107651_bib24","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-15-0139","article-title":"Tuning sensitivity of CAR to EGFR density limits recognition of normal tissue while maintaining potent antitumor activity","volume":"75","author":"Caruso","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2024.107651_bib25","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood-2017-08-802926","article-title":"Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination","volume":"132","author":"Akahori","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2024.107651_bib26","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/adt.2006.4.545","article-title":"Live cell quality control and utility of real-time cell electronic sensing for assay development Assay","volume":"4","author":"Kirstein","year":"2006","journal-title":"Drug Dev. Technol."},{"key":"10.1016\/j.jbc.2024.107651_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aao5838","article-title":"Mammalian EAK-7 activates alternative mTOR signaling to regulate cell proliferation and migration","volume":"4","author":"Nguyen","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2024.107651_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn7336","article-title":"BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion","volume":"14","author":"Jung","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2024.107651_bib29","doi-asserted-by":"crossref","DOI":"10.3791\/3683","article-title":"Determining optimal cytotoxic activity of human Her2neu specific CD8 T cells by comparing the Cr51 release assay to the xCELLigence system","author":"Erskine","year":"2012","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.jbc.2024.107651_bib30","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.4049\/jimmunol.123.6.2870","article-title":"Mechanism of cell-mediated cytotoxicity at the single cell level","volume":"123","author":"Grimm","year":"1979","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jbc.2024.107651_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.immuni.2016.01.010","article-title":"In\u00a0vivo killing capacity of cytotoxic T cells is limited and involves dynamic interactions and T cell cooperativity","volume":"44","author":"Halle","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2024.107651_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coi.2015.01.003","article-title":"TCR affinity for p\/MHC formed by tumor antigens that are self-proteins: impact on efficacy and toxicity","volume":"33","author":"Stone","year":"2015","journal-title":"Curr. Opn. Immunol."},{"key":"10.1016\/j.jbc.2024.107651_bib33","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1158\/1078-0432.CCR-17-1012","article-title":"T-cell receptors for clinical therapy: in\u00a0vitro assessment of toxicity risk","volume":"23","author":"Kunert","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2024.107651_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-cellbio-120219-055100","article-title":"Mechanobiology of T cell activation: to catch a bond","volume":"37","author":"Liu","year":"2021","journal-title":"Ann. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.jbc.2024.107651_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1154074","article-title":"Two-dimensional measurements of receptor-ligand interactions","volume":"10","author":"Zheng","year":"2023","journal-title":"Front Mol. Biosci."},{"key":"10.1016\/j.jbc.2024.107651_bib36","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nri3728","article-title":"Phenotypic models of T cell activation","volume":"14","author":"Lever","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2024.107651_bib37","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1073\/pnas.79.2.608","article-title":"Cell surface properties of HLA antigens on Epstein-Barr virus-transformed cell lines","volume":"79","author":"Smith","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107651_bib38","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.3390\/cancers15123081","article-title":"CD28 and 41BB costimulatory domains alone or in combination differentially influence cell surface dynamics and organization of chimeric antigen receptors and early activation of CAR T cells","volume":"15","author":"Mezosi-Csaplar","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2024.107651_bib39","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma","volume":"122","author":"Linette","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2024.107651_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(01)00185-4","article-title":"T\u00a0cell receptor-MHC interactions up close","volume":"104","author":"Hennecke","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107651_bib41","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.immunol.23.021704.115658","article-title":"How TCRs bind MHCs, peptides, and coreceptors","volume":"24","author":"Rudolph","year":"2006","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/j.jbc.2024.107651_bib42","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1172\/JCI92335","article-title":"A\u00a0therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide\/HLA-I antigens","volume":"127","author":"Chang","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2024.107651_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adj5792","article-title":"Structural principles of peptide-centric chimeric antigen receptor recognition guide therapeutic expansion","volume":"8","author":"Sun","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jbc.2024.107651_bib44","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/1535-7163.MCT-19-1110","article-title":"Phenotypic models of CAR T-cell activation elucidate the pivotal regulatory role of CAR downmodulation","volume":"20","author":"Greenman","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2024.107651_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cell.2014.02.053","article-title":"Accumulation of dynamic catch bonds between TCR and agonist peptide-MHC triggers T cell signaling","volume":"157","author":"Liu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107651_bib46","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.it.2018.05.005","article-title":"Alphabeta T Cell receptor mechanosensing forces out serial engagement","volume":"39","author":"Feng","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jbc.2024.107651_bib47","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cell.2018.06.017","article-title":"Isolation of a structural mechanism for uncoupling T cell receptor signaling from peptide-MHC binding","volume":"174","author":"Sibener","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107651_bib48","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.1021\/acs.jpclett.1c02240","article-title":"Single molecule force spectroscopy reveals distinctions in key biophysical parameters of \u03b1\u03b2 T-cell receptors compared with chimeric antigen receptors directed at the same ligand","volume":"12","author":"Banik","year":"2021","journal-title":"J.\u00a0Phys. Chem. Lett."},{"key":"10.1016\/j.jbc.2024.107651_bib49","doi-asserted-by":"crossref","first-page":"16943","DOI":"10.1073\/pnas.1902141116","article-title":"TCR-pMHC kinetics under force in a cell-free system show no intrinsic catch bond, but a minimal encounter duration before binding","volume":"116","author":"Limozin","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107651_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/science.abl5282","article-title":"Tuning T cell receptor sensitivity through catch bond engineering","volume":"376","author":"Zhao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107651_bib51","first-page":"2543","article-title":"Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines","volume":"116","author":"McMahan","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2024.107651_bib52","article-title":"Attenuated T cell responses to a high-potency ligand in\u00a0vivo","volume":"8","author":"Marrack","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jbc.2024.107651_bib53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107651_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5191","article-title":"Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2024.107651_bib55","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41591-021-01621-1","article-title":"HLA-independent T cell receptors for targeting tumors with low antigen density","volume":"28","author":"Mansilla-Soto","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2024.107651_bib56","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.ymthe.2017.06.008","article-title":"Tumor antigen and receptor densities regulate efficacy of a chimeric antigen receptor targeting anaplastic lymphoma kinase","volume":"25","author":"Walker","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbc.2024.107651_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl3995","article-title":"Size-dependent activation of CAR-T cells","volume":"7","author":"Xiao","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jbc.2024.107651_bib58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1074-7613(03)00019-0","article-title":"Quantitative analysis of the contribution of TCR\/pepMHC affinity and CD8 to T cell activation","volume":"18","author":"Holler","year":"2003","journal-title":"Immunity"}],"updated-by":[{"DOI":"10.1016\/j.jbc.2024.108008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000}}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824021525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824021525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:59:19Z","timestamp":1777413559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824021525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0021925824021525"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107651","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"107651"}}